Help Heal
Your Skin
From Within

DUPIXENT treats people 6 years of age and older with moderate-to-severe atopic dermatitis that is not well controlled with topical prescription therapies.

Learn About DUPIXENT
Jason,
Real patient. Individual results may vary.
Shawn,
Real patient. Individual results may vary.

Revolutionary treatment and first
biologic of its kind to help continuously
treat moderate-to-severe eczema

Helps manage the inflammation deep
beneath the surface that contributes
to the flare-ups on the skin

Prescription medicine given under the skin (subcutaneous injection) that is not a steroid or cream

The DUPIXENT 300 mg pre-filled

pen is now available for


ages 12+ years!

It's another approach to dosing.

DUPIXENT is given as an injection under the skin (subcutaneous injection) into different injection sites. You must be shown the right way by your healthcare provider before injecting DUPIXENT. And, with a hidden needle, you won't see it before, during, or after the injection.

Get more info

A Breakthrough Eczema Treatment

DUPIXENT was studied in people 6 years of age and older.
See the clinical results by choosing adults (18+), teens (12-17), or children (6-11).

For Adults
(Ages 18+)

DUPIXENT was studied in 3 clinical trials with more than 2,100 adults with moderate-to-severe eczema not well controlled with topical prescription treatments. It was first approved by the FDA on March 28, 2017.

View Results
in Adults
Jennifer,
Real patient. Individual results may vary.

For Teens
(Ages 12-17)

DUPIXENT was studied in a 16-week clinical trial with 251 patients ages 12-17 years with moderate-to-severe eczema not well controlled with topical prescription treatments. It was approved by the FDA for this patient population on March 11, 2019.

View Results
in Teens
Noah,
Real patient. Individual results may vary.

For Children
(Ages 6-11)

DUPIXENT was studied in a 16-week clinical trial with 367 patients ages 6-11 years with severe eczema not well controlled with topical prescription treatments. It was approved by the FDA for the moderate-to-severe patient population on May 26, 2020.

View Results
in Children
Not a real patient.

DUPIXENT MyWay® Copay Card

The DUPIXENT MyWay Copay Card may help cover the out-of-pocket cost of DUPIXENT. If you’re eligible, you can sign up and download your copay card on the site. Terms & Restrictions Apply.

See Copay Details

DUPIXENT MyWay also offers Nurse Educator Support, supplemental injection training online or in person, and more.

See more information

Real Patient Experiences

Everyone has a story to tell. Hear from DUPIXENT
ambassadors as they share their messages and
lessons they’ve learned.

Hear Their Stories

Shawn,
Real patient. Individual results may vary.

Find a Specialist Who
Treats Eczema

Use this Healthgrades™ tool to easily find nearby specialists with experience in treating children, teens, and adults with uncontrolled moderate-to-severe eczema (atopic dermatitis).

Are you sure you want to leave?
Please note: By clicking on this link, you will be leaving this Sanofi-hosted US website and going to another, entirely independent website. Sanofi US and Regeneron provide these links as a service to its website visitors and users; however, they take no responsibility for the information on any website but their own.